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ABSTRACT 
Advanced parental age has been linked to adverse health effects in the offspring including childhood acute 
lymphoblastic leukemia (ALL), as shown in a large scale meta-analysis of published data. We aimed to further explore 
the association using primary data from 11 case-control studies (7919 cases; 12942 controls) and 5 nested case-control 
studies (8801 cases; 29690 controls) of the Childhood Leukemia International Consortium (enrollment periods 1968-
2015). Following application of fractional polynomials, maternal and paternal age - with and without mutual adjustment 
- were introduced as 5-year continuous variables in pooled unconditional logistic regression analyses, as well in meta-
analyses by study design using maximally adjusted odds ratios (OR) derived from each of the 16 individual 
study results. Increasing paternal age was associated with higher risk for childhood ALL (ORpooled:1.08 per 5-year 
increment, 95% CI: 1.04-1.11; ORcase-control: 1.05, 95% CI:1.00-1.11; ORnested:1.04, 95% CI: 1.01-1.07). By contrast, a 
similar positive association with advanced maternal age was found only in the nested case-control studies (ORpooled:0.92, 
95% CI: 0.89-0.96; ORcase-control:0.99, 95% CI: 0.91-1.07, heterogeneity I2=58%, p=0.002; ORnested:1.05, 95% CI: 1.01-
1.08). The findings were confined to ages 1-5 years and practically unchanged by mutual adjustment for the collinear 
parental age variables; analyses of discordant parental age pairs from nested case-control studies was limited by the 
relatively small numbers. In conclusion, the most valid nested case-control studies add evidence regarding the role 
of advanced parental age in ALL risk; further analyses by cytogenetic subtypes could further disentangle the effect and 
underlying mechanisms. 
Key words: maternal age; paternal age; childhood acute lymphoblastic leukemia; collinearity; 
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INTRODUCTION 
Acute lymphoblastic leukemia (ALL) accounts for 25-30% of all cancers in children (1). Several 
treatment breakthroughs in the last 50 years have contributed to an >80% increase in survival of 
this most common childhood malignancy (2). Less progress has been made, however, in 
understanding the genetic, environmental and lifestyle risk factors of leukemogenesis (3); 
individual studies and large consortia, such as the Childhood Leukemia International Consortium 
(CLIC) (4), are currently exploring the constellation of these factors with progress on the role of 
birth anthropometrics (5), indicators of early immune stimulation (6), prenatal maternal 
supplementation with folic acid and vitamins (7), as well as pre-labor cesarean delivery (8, 9). 
Stipulations on a prenatal origin of childhood ALL have been expressed in the past and already 
explored (10-12), whereas several studies have also examined the potential role of parental 
reproductive factors. In particular, maternal and paternal age at birth represent several potential 
factors, including socio-economic components, life decisions, fertility issues and cultural 
dynamics (13). Over the recent decades, the increasing trends of parental age at first delivery 
worldwide, on account mainly of career pursuit and awareness of fertility treatment availability, 
have attracted intense scientific interest due to reported consequences on offspring’s health (14, 
15). Indeed, advanced maternal age has been linked to a series of adverse pregnancy outcomes 
(16) and a dramatic increase in the risk of chromosomal abnormalities (17). Albeit less studied, 
advanced paternal age has been so far associated with single gene mutations birth defects, 
chromosomal abnormalities and neurodevelopmental disorders in the offspring (18). Thus, 
genomic sequencing studies have shown higher numbers of de novo mutations in the offspring of 
older parents (19, 20) and decreased DNA methylation patterns (21), potentially increasing 
offspring vulnerability to carcinogenesis (21, 22). 
Advanced maternal but also paternal age at birth of the offspring has been associated with 
increased childhood ALL risk in the meta-analysis of numerous case-control and cohort studies; 
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marginally increased associations with young maternal and paternal age were also observed (23). 
Registry-based, record-linkage studies from California and Denmark using nested case-control 
designs have also found an increased ALL risk with advanced maternal age and marginally 
positive associations with older paternal age (24-26). Inherent methodological concerns, especially 
when synthesizing published data from individual studies to explore the parental age associations 
with the disease include inadequate control for confounding in underpowered studies, tentatively 
suboptimal use of continuous instead of categorical analysis or arbitrary determination of cut-off 
points for the two variables of interest, notably paternal and maternal age. Most importantly, 
collinearity between maternal and paternal age precludes clear attribution of the effect to sole 
maternal, sole paternal or dual parental impact. An additional limitation in meta-analysis of case-
control studies is the invoked participation bias when control recruitment  is conducted via 
interviews (27).  
In this study, we used primary data from 15 case-control or nested case-control studies within 
CLIC conducted in 12 countries worldwide aiming to overcome, to the extent possible, several of 
the aforementioned shortcomings encountered in meta-analysis of published data (4). Specifically, 
we opted to compare the results from case-control studies taking into account their nationwide 
coverage and control representativity with those of nested case-control studies using cancer 
registration data for the case series and record-linkage for control selection and maximally adjust 
for potential confounders in pooled analyses, in meta-analyses or in sub-analyses and sensitivity 
analyses, as appropriate. To understand any differential effect of each of the two main variables of 
interest, we explored the individual and joint impact of parental age in multivariate models; 
furthermore, we assessed the effect in combinations of concordant and discordant parental age 
pairs with childhood ALL in the largest ever dataset of primary data on the topic. 
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METHODS 
Study designs and availability of data 
Individual-level (primary) data contributed by 15 studies participating in CLIC were used. Among 
them, four were population-based record-linkage nested case-control studies (Canada, Denmark, 
Finland, Washington). In addition to the primary data provided by these studies, summary effects 
were provided from the record-linkage population-based nested case-control study based on data 
for pediatric leukemia from the California Cancer Register (CCRLP), which were by necessity 
included only in meta-analyses. 
Characteristics of the participating studies, along with the contributed number of cases and 
number of controls per case, and basic information on case and control recruitment (provided by 
the individual study principal investigator), are presented in Supplementary Table 1. All study 
subjects, namely cases with ALL and their controls were aged <15 years at diagnosis/recruitment. 
Children with a diagnosis of Down syndrome were excluded to avoid a major confounder.  
 Data collection and harmonization 
According to the study protocol, CLIC studies contributed primary data on a series of a priori 
selected variables; the data were subsequently reviewed and harmonized by the Nationwide 
Registry for Childhood Hematological Malignancies and Solid Tumors (NARECHEM-ST) team. 
In the interview-based studies, the main exposure variables, namely maternal and paternal age at 
birth, were self-reported via face-to-face or telephone interviews usually conducted with the 
child’s mother; in record-linkage studies, the variables were extracted from the registry data. Data 
on index child’s age at diagnosis or recruitment, sex, ethnicity, birth weight, gestational age, 
maternal educational level, multiplicity, birth order, maternal smoking during pregnancy, as well 
as diagnosis of maternal diabetes during pregnancy and alcohol consumption in pregnancy had 
been also requested. The availability of each variable per study is presented in Supplementary 
Table 2. In the present analysis, maternal educational level was used as a proxy for socioeconomic 
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status and was harmonized as low (below completion of secondary education), intermediate 
(completion of secondary education) or high (college, university or higher degree) depending on 
individual study definition. Following an all-studies-inclusive policy in the analysis, a combined 
variable was constructed, defining pre-term birth as gestational age <37 weeks to account for the 
exact gestational age missing values in the study of Costa Rica. Likewise, regarding ethnicity 
(coded as Caucasian/non-Caucasian), as ~99% of the Danish population are of Caucasian origin 
and the ethnicity variable was missing, all subjects in the Danish dataset were considered 
Caucasians.  
Statistical analysis 
For the purposes of the pooled analyses, a maximum of randomly chosen 3-4 controls per case 
based on age (<1, 1-4, 5-9, 10-14 years) frequency matching and sex were used in the nested case-
control studies.  
Pooled multivariate logistic regression using the individual-level data was used to explore the role 
of maternal and paternal age at birth on childhood ALL risk. Covariates included in the 
multivariate model were determined a priori based on the associations between the available 
variables described in the literature and graphically presented in a conceptual directed acyclic 
graph (DAG; Supplementary Figure 1) and the availability of variables. The covariates were 
child’s ethnicity (Caucasian vs. non-Caucasian), birth weight (continuous; 500 g increments), 
maternal education (categorical; low, intermediate [reference], high), maternal smoking during 
pregnancy (yes vs. no), pre-term birth (yes vs. no), multiple pregnancy (yes vs. no), birth order 
(continous; 1, 2, or ≥3), maternal diabetes during pregnancy (yes vs. no) and alcohol consumption 
during pregnancy (yes vs. no). All models were additionally adjusted for the matching variables of 
child’s age (categorical; <1, 1-4 [reference], 5-9, 10-14 years), sex (male vs. female) and time 
period at diagnosis/recruitment (categorical; 1968-1993, 1994-2003 [reference], 2004-2015). Only 
six of the 16 studies collected data on maternal diabetes and alcohol consumption during 
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pregnancy (covering 28% and 32% of the total dataset, respectively); hence, these two variables 
were excluded from subsequent analyses. Based on the availability of the remaining variables 
across the individual studies, two different models were designed; a partially adjusted model, 
including child’s age, sex, ethnicity, time period at diagnosis/recruitment, birth weight and 
maternal education, as well as a maximally adjusted model further controlling for maternal 
smoking during pregnancy, pre-term birth, birth order and multiple pregnancy. 
To examine the relationship between paternal and maternal age and risk of childhood ALL, 
fractional polynomials ascertained the best-fitting curves across the pooled dataset. Since linear 
relationships could not be improved upon (p>0.10) for either maternal or paternal age, when 
examined separately or concurrently (data not shown), we primarily included maternal and 
paternal age in our analyses as 5-year age groups treated as continuous variables. To further assess 
the risk by specific parental age categories, analyses classifying maternal and paternal age in 3 
groups (<25 [reference], 25-34, ≥35 years) were also peformed. On account of the collinearity 
between maternal and paternal age, the two variables were included in the model as paternal only, 
maternal only or concurrently paternal and maternal age.  
Meta-analyses of study-specific risk estimates were thereafter undertaken, by pooling risk 
estimates calculated from multiple logistic regression models for each study. In the study-specific 
analyses, the maximally adjusted model based on the aforementioned covariates was preferred, as 
to thoroughly control for confounding; variables with >20% missing values within the individual 
studies were excluded from the study-specific multivariate model. Based on the individual study 
design, conditional or unconditional logistic regression analyses were performed. Maternal and 
paternal age were concurrently included in the model in all analyses. For the meta-analysis, 
random-effects models were implemented and heterogeneity across studies was evaluated with the 
Cochran Q and I2 statistics.  A p-value <0.10, as derived from the Cochran Q test was considered 
to indicate statistically significant presence of heterogeneity.  
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To evaluate potential bias due to method of parental age assessment, we conducted subgroup 
meta-analyses and sensitivity analyses of the available nested case-control studies (Canada-
Quebec, Denmark, Finland, Washington State and California State, CCRLP) with medical record 
linkage. Subsequently, a variable comprising all 9 pairs of maternal (young, intermediate, 
advanced) X paternal (young, intermediate, advanced) age combinations was created, aiming to 
disentangle the overall collinear effect of the two exposure variables and was used in a meta-
analysis of the five nested case control studies. Subgroup meta-analyses by child’s age group (<1, 
1-5, 6-14 years), sex, time period of diagnosis/recruitment and child’s ethnicity were additionally 
conducted to assess effect modification.  
Lastly, to assess the effect of potentially unmeasured confounding on our results, the E-value was 
estimated (28), based on maximally adjusted effect estimates for categories of maternal and 
paternal age on the risk for childhood ALL among the record-linkage population-based studies. E-
values indicate the size of the effect estimate that potentially unmeasured or uncontrolled 
confounding should have to totally attenuate the observed associations. 
Statistical analyses were conducted with SAS 9.4 version and STATA 14.1 version.  
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RESULTS 
Distribution of the study variables 
The 15 participating studies provided data for a total of 11,799 ALL cases and 25,900 controls, 
with maternal age being available for 11,696 cases and 25,702 controls and paternal age for 
11,276 cases and 24,638 controls (Table 1). The time period of diagnosis or recruitment ranged 
from 1968 to 2016, and the majority of the participants (83% of cases and 87% of controls) were 
of Caucasian origin.  
The distribution of maternal and paternal age at birth was highly variable across studies (Figure 1). 
The lowest frequency of maternal age at birth <25 years (12%) among controls was reported in the 
Italian study, whereas the respective proportions were 46% in Costa Rica and 54% in Brazil. More 
than 15% of participating cases and controls had maternal age at birth ≥35 years in California-
CCLS, Finland, Greece, and Italy, as opposed to the lowest frequencies reported in Canada-
Quebec (6%) and the E15-COG study (8%). Proportions of controls with paternal age at birth ≥35 
years ranged from <20% in Canada-Quebec and the E15-COG study to >35% in Egypt, Greece 
and Italy; paternal age <25 years ranged from 3% (Italy) and 7% (Greece) to 32% (Texas) and 
34% (Brazil).   
 
Maternal and paternal age associations with childhood ALL  
1. Pooled analyses and meta-analyses of 15 studies 
Data from pooled analyses of all 15 studies (Table 2) show that increasing maternal age at birth 
was associated with a decreased risk for childhood ALL (fully adjusted OR: 0.92 per 5-year 
increment, 95% CI: 0.89-0.96); by contrast an increased risk with increasing paternal age (5-year 
increment; fully adjusted OR: 1.08, 95% CI: 1.04-1.11) was found. The same trends were noted in 
the categorical fully adjusted analyses, notably the ORs for maternal age ≥35 was 0.84 (95% CI: 
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0.74-0.95) and for 25-34 years 0.90 (95% CI: 0.83-0.98), compared to <25 years . Paternal age 
≥35 years was associated with a 17% increased odds (OR: 1.17, 95% CI: 1.04-1.32) for childhood 
ALL. Practically identical findings were obtained in partially adjusted models with larger number 
of cases and controls. Further adjustment for study site, as well as alternative introduction of the 
maternal or paternal age variable in the models, did not essentially change the results (data not 
shown). 
The meta-analysis (right panel of Table 2 and Supplementary Figure 2) confirmed the higher risk 
for childhood ALL imparted by increasing paternal age (OR5-year increment: 1.05, 95% CI: 1.02-1.09; 
OR≥35 vs. <25 years: 1.18, 95% CI: 1.03-1.36; no substantial heterogeneity), but not with increasing 
maternal age (OR5-year increment: 1.00, 95% CI: 0.95-1.06; OR≥35 vs. <25 years: 0.98, 95% CI: 0.84-1.15; 
statistically significant heterogeneity). After excluding one study at a time, the incremental effect 
of paternal age on the risk for childhood ALL remained statistically significant in all analyses and 
the effect of maternal age did not considerably vary (Supplementary Figure 3). 
 
2. Meta-analysis by study design (5 population-based record-linkage studies vs. 11 case-
control studies) 
Following the statistically significant heterogeneity revealed for the maternal age meta-analysis 
and the non-converging results of the pooled analyses with those of the meta-analysis, we 
proceeded with subgroup meta-analyses by the method of control recruitment; thus, separate 
analyses of the 11 case-control studies (including the Californian CCLS) based on interview-based 
vs. record linkage case-control studies were performed (Figure 2); in addition, the Californian 
CCRLP-derived summary effect estimates were added to the 4 record linkage studies providing 
primary data, with five record linkage studies included in the meta-analysis.  
Results derived for the maternal age from case-control studies (OR5-year-increment: 0.99, 95% CI: 
0.91-1.07; heterogeneity I2: 64%, p=0.002) were in stark contrast with those derived from the 
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record-linkage ones; as expected, the latter demonstrated a statistically significant increased risk 
for childhood ALL with increasing maternal age (OR5-year-increment: 1.05, 95% CI: 1.01-1.08; I2: 0%, 
p=0.64). Of note, irrespective of control recruitment methodology, similar results were obtained 
regarding the association of increasing paternal age with childhood ALL risk, (non-record-linkage 
studies, OR5-year-increment: 1.05, 95% CI: 1.00-1.11, I2: 29%, p=0.17 vs. record-linkage studies: OR5-
year-increment: 1.04, 95% CI: 1.01-1.07; I2: 0%, p=0.86). The categorical meta-analyses 
(Supplementary Figure 4) showed comparable results. Essentially similar results were also 
obtained when repeating the analyses introducing only the maternal or only the paternal age 
variable in the model (data not shown). 
 
Collinearity of paternal with maternal age 
All subsequent meta-analyses were conducted using the five population-based record-linkage 
studies. Table 3 shows the grid of concordant (both parents in the same age group) and discordant 
maternal and paternal age groups (each parent in different age groups), in an effort to assess the 
combined effect of maternal and paternal age at birth on childhood ALL risk. Overall, results of 
the concordant cells confirm the findings that the highest odds were noted for the combined 
category of both parents’ age ≥35 years (OR: 1.16, 95% CI: 1.04-1.28), whereas when both 
parents were <25 years at birth, the child was at decreased risk for ALL (OR: 0.84, 95% CI: 0.77-
0.91). These cells, however, are non-informative in disentangling collinearity. Although 
underpowered, cells with the informative discordant age categories, notably younger than 25 years 
maternal and ≥35 years paternal age (OR: 1.17; 95% CI: 0.77-1.77) and intermediate/old maternal 
age (≥25 years) and young paternal age (<25 years; OR: 0.88; 95% CI: 0.74-1.04) may be 
interpreted as showing a tentatively stronger effect of older paternal age on childhood ALL risk, 
without reaching however, statistical significance. 
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Subgroup analyses  
Table 4 presents results of sub-analyses by child’s age group, sex, ethnicity and time period at 
diagnosis/ recruitment. The association with both paternal and maternal age is confined to the age 
group 1-5 years; for advanced maternal age, similar positive association with ALL is evident for 
both genders and non-Caucasian ethnicity, as opposed to the positive association of the advanced 
paternal age with ALL risk confined to boys and Caucasian ethnicity.  
 
Unmeasured confounding 
The fully adjusted effect estimates for maternal and paternal age ≥35 years (ORs: 1.16 and 1.18, 
respectively) in the maximally adjusted record-linkage studies meta-analyses, corresponded to E-
values of 1.59 and 1.64, respectively, whereas the respective E-values for the low 95% confidence 
intervals were 1.28 and 1.24.  
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DISCUSSION 
This large size CLIC study including primary data from 11 case control (7919 cases; 12,942 
controls) and 5 nested case control studies (8801 cases; 29,690 controls), yielded a statistically 
significant and linearly increasing risk for childhood ALL with advancing paternal age. In line 
with a recently published meta-analysis, the five record-linkage studies also showed an increasing 
risk with advancing maternal age; underlying reasons for the contradictory and heterogeneous 
results derived from few interview-based case-control CLIC studies, such as selectin bias, should 
be further explored. The results were practically unchanged when the two variables of interest 
were alternatively or jointly introduced in the multivariate models; compared to the non-
informative concordant on parental age pairs, analysis of the fewer discordant parental age pairs, 
may be interpreted as pointing to paternal age as the main determinant of ALL risk compared to 
maternal age; disentangling collinearity in parental age should, however, be further explored. 
Ιn terms of effect directionality and magnitude, our results are in line both with those of the 
recently published meta-analysis of 77 studies showing a higher risk for ALL with advanced age 
of both mother and father (23), with the exception of the maternal age association estimates 
derived solely from register-based case-control studies within CLIC. Separate analyses by study 
design –cohort vs. case control – had also been undertaken in the 2015 meta-analysis (23), albeit 
no attempt was then employed to tackle collinearity between the two exposure variables of 
interest. Moreover, results in the large series of case-control studies conducted worldwide showing 
a positive association with maternal age were not mutually adjusted for paternal age. Likewise, the 
results from the two included population-based cohort studies were positive, notably one from the 
region of Piedmont in Italy (29) and the registry-based nationwide study of Denmark (30), as well 
as those of two recent population-based case-control studies in California and again Denmark, the 
latter confined only to the paternal associations (24-26). 
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The paternal age association was consistent and of similar size across different study 
methodologies and robust in both the CLIC pooled analysis and meta-analysis, without evidence 
of heterogeneity. The findings, however, were not similar for maternal age; surprisingly, however, 
an inverse association of advanced maternal age with ALL risk was found in the pooled analysis 
entailing all study designs; a null effect in considerably heterogeneous random-effects meta-
analysis; and a positive, non-heterogeneous one in the sensitivity analyses of the five population-
based record-linkage studies less prone to biases. The sources of error leading to an inverse or null 
associations with advancement of maternal age, found in some classic CLIC case control studies, 
cannot be easily explored. This may be partly attributed to differential control recruitment in case-
control studies, especially non-participation bias, as previously reported by the German study, also 
included in the present analysis of primary data, showing a deficit in the young age in maternal 
distribution among selected controls in comparison to that in the underlying population (27). 
Specifically, the majority of controls are derived following maternal consent in case-control 
studies of childhood cancer and this might possibly explain why these differences were evident 
only for maternal, and not for paternal age, distributions.  
Population-based studies, in which both cases and the comparison group are derived from record 
linkage of cancer registry population data, are considered free from selection bias due to non-
participation. In this CLIC study, researchers from California contributed primary data from an 
interview-based recruitment case-control study (CCLS), as well as effect estimates from the record 
linkage case-control study (CCRLP). The CCLS case-control study, comprising subjects not 
included in the larger and lengthier CCRLP study, yielded an inverse association of maternal age 
with ALL, whereas the latter clearly showed a higher risk with increasing maternal age. Of note, 
the mean maternal age of controls in CCLS was almost 2 years older compared to the CCRLP 
study (29.3 vs. 27.4 years); while no such difference was noted among leukemia cases (28.2 vs. 
27.8 years). Not all CLIC case control studies, however, are subject to the same bias. For example, 
there seemed to be no difference in the age distribution of the Greek NARECHEM-ST control 
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series in maternal age at fist pregnancy  compared with the national statistics. Similarly, the 
maternal age distribution among controls in the Italian SETIL study followed the population 
pattern. Of note, however, both the Greek and the Italian studies had parental age distributions 
heavily skewed towards older age categories, i.e. there was little variation in the exposure 
variables of interest, possibly contributing to the null associations for maternal age.  
Unlike record-linkage studies, the classic interview-based case-control studies can also be subject 
to recall bias; it is considered unlikely, however, that there might be major reporting inaccuracies 
with regards to the age of parental age at index child’s birth (31). Worth noting are the large 
differences across CLIC studies regarding the age distributions of the two exposure variables of 
interest; the between-study parental age differences probably reflect socioeconomic and cultural 
variations between populations. Age distributions show dramatic increases in maternal and 
paternal age in the recent decades (14, 15); their distribution across the studies essentially depends 
on the study period, which could span almost five decades (1968-2015). The case to control ratio 
in the nested case-control studies ranged from 1:1 to 1:100, the latter aiming to increase precision 
for rare exposures; in order to reduce the impact of the heavy imbalance on the effect estimates, 
especially in pooled analyses, the investigators randomly selected controls in a ratio of  
approximately 1:3 for studies with more than 1 controls per case.  
In both the pooled and the study-specific analyses, we aimed to include the maximum number of 
available co-variates in the multiple regression models. Thus, we adjusted for most perinatal 
factors that have been implicated as potential confounders in the literature. Nevertheless, given the 
high proportion of missing values for some covariates or individual studies, it was not eventually 
possible to control for alcohol consumption (32), maternal diabetes during pregnancy (33), 
breastfeeding (34) or genetic markers. To further assess for the potential effect of unmeasured 
confounding, however, we assessed its magnitude by calculating the recently described E-value 
(28). In order to sufficiently explain the observed effect estimates for both maternal and paternal 
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age, as derived from population-based record-linkage studies, an unmeasured confounder should 
impact on the risk of childhood ALL with an effect estimate of a level of 1.6, which is considered 
quite high, given the magnitude of the associations with the perinatal factors that have already 
been described in the literature.  
The high collinearity between the two main variables of interest restricted our ability to 
disentangle whether advanced maternal, paternal or joint parental age contribute to ALL risk. To 
this end, we opted to include separately each variable in the models, whereas the two variables 
were simultaneously introduced in subsequent models; the results, remained practically the same. 
Lastly, the discordant maternal and paternal age pairs used in a joint analysis of the record-linkage 
studies showed some indication that advanced paternal age might be more important, albeit the 
findings were imprecise. 
Several outcomes, including chromosomal abnormalities (17, 18), neurodevelopmental disorders 
(35, 36), psychiatric diseases (37, 38) and cancer (26) in the offspring have been associated with 
older parental age. Accumulation of de novo genetic mutations in the paternal germ cells (19, 20) 
that could increase the risk for childhood cancer (39, 40) is a plausible explanation for the 
association with advanced paternal age. Moreover, DNA methylation in the offspring related to 
advanced maternal age was correlated with cancer in an epigenome-wide association study (21). 
The well-established association of advanced maternal age with chromosomal abnormalities and 
birth defects (41, 42) as well as ALL (43-45) could possibly mediate the observed effect; of note, 
we excluded children with Down syndrome, who are more likely to develop the disease. 
According to the findings from the record-linkage studies, the magnitude of the impact of 
advanced maternal and paternal age seemed to be rather small (5% and 4% per 5-year increment, 
respectively); the figure can be translated to a ~20% increase in the risk for a 20-year increase in 
parental age. Nevertheless, it may have substantial public health relevance, given the recent sharp 
increase of parental age at birth of first child worldwide (14, 15). Indeed, previous studies have 
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suggested that increasing maternal and paternal ages might contribute to the increasing trend in the 
rates of childhood ALL (1, 46-48) (26, 29). 
The strengths of the present CLIC study include the large numbers of cases and controls that also 
allowed to explore robustness of the observed associations in several sub-analyses; the availability 
of two study designs for testing etiological hypotheses while assessing the potential effect of study 
design on the results. Besides the experience from conducting the 2015 meta-analysis that guided 
the current analyses, the results of the pooled analysis were contrasted to those derived from the 
meta-analysis of the individual study results. Among the limitations of the study are the divergent 
data collection methods for cases and controls, as well as divergent time periods and parental age 
distributions between studies, and minimal exposure variation in some studies; the high 
proportions of missing values in several essential covariates, including confounding factors, which 
led to considerable decrease of the sample size in the fully-adjusted analyses; the heterogeneity 
regarding the distribution of maternal and paternal age among studies; lastly, lack of ALL 
immune-phenotype data in the majority of the studies, especially the record linkage studies.  
In conclusion, we used the largest set of primary data so far exploring the association of parental 
age at birth with childhood ALL and the results demonstrated an association of advanced parental 
with increased risk, which is consistent with earlier reports. De novo mutations in the fathers’ 
germ cells and epigenetic alterations in the offspring born to older mothers could explain the 
observed associations. Methodological challenges related to methods of control selection and data 
collection, as well as unmeasured confounding should be further explored within CLIC. 
Longitudinal cohort studies with cytogenetic data are important to broaden our understanding on 
the mechanisms through which advanced maternal and paternal age affect leukemogenesis among 
children.  
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Table 1. Distributions of cases with acute lymphoblastic leukemia (ALL) and controls by the study 
variables. 
Variables 
ALL Cases (N=11799) Controls (N=25900) 
N % N % 
Index child’s age at 
diagnosis/recruitment (years)     
<1  444 3.8 1636 6.3 
1-4  6392 54.2 12837 49.6 
5-9  3367 28.5 7216 27.9 
10-14  1596 13.5 4211 16.2 
Index child’s sex     
Male 6565 55.6 14057 54.3 
Female 5234 44.4 11842 45.7 
Time period of 
diagnosis/recruitment     
1968-1993 4536 38.4 9848 38.0 
1994-2003 4281 36.3 9979 38.5 
2004-2016 2982 25.3 6073 23.5 
Index child’s ethnicity     
Caucasian 9780 83.1 22378 86.7 
Non-Caucasian 1990 16.9 3443 13.3 
Missing 29 0.3 79 0.3 
Birth weight (g)     
<2500 584 5.2 1391 5.7 
2500-2999  1556 13.9 3612 14.8 
3000-3499 3968 35.5 8690 35.6 
3500-3999 3493 31.2 7521 30.9 
≥4000  1590 14.2 3166 13.0 
Missing 608 5.2 1520 5.9 
Maternal education     
Low 2507 23.3 4882 22.1 
Intermediate 5426 50.5 11081 50.2 
High 2813 26.2 6104 27.7 
Missing 1053 8.9 3833 14.8 
Maternal smoking during 
pregnancy     
No 8305 78.5 17144 79.2 
Yes 2272 21.5 4498 20.8 
Missing 1222 10.4 4258 16.4 
Pre-term birtha     
No 8900 92.8 19124 93.2 
Yes 692 7.2 1393 6.8 
Missing 2207 18.7 5383 20.8 
Multiple pregnancy     
No 9854 97.5 20938 97.7 
Yes 251 2.5 495 2.3 
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Missing 1694 14.4 4467 17.3 
Birth order     
1 5066 44.9 10976 44.2 
2 3867 34.3 8543 34.5 
≥3 2348 20.8 5275 21.3 
Missing 518 4.4 1106 4.3 
Maternal age at birth (years)     
<20 687 5.9 1470 5.7 
20-24 2699 23.1 5802 22.6 
25-29 3958 33.8 8861 34.5 
30-34 2970 25.4 6528 25.4 
≥35 1382 11.8 3041 11.8 
Missing 103 0.9 198 0.8 
Mean ± SD 29.92 ± 5.48 29.96 ± 5.46 
Paternal age at birth (years)     
<25 1628 14.4 3587 14.6 
25-29 3286 29.1 7471 30.3 
30-34 3413 30.3 7505 30.4 
35-39 1900 16.9 3979 16.2 
≥40 1049 9.3 2096 8.5 
Missing 523 4.4 1262 4.9 
Mean ± SD 31.11 ± 6.41 30.90 ± 6.25 
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Table 2. Odds Ratios (OR) and 95% Confidence Intervals (95% CI) derived from multiple logistic regression analysis of the pooled data or random-effects 
meta-analysis for the association of maternal and paternal age with childhood (0-14-year-old) acute lymphoblastic leukemia (ALL). 
Variable 
Pooled analysis (partially adjusted 
model)a Pooled analysis (fully adjusted model)
b Meta-analysisc 
N ALL 
cases 
N 
controls 
OR 
(95% CI) 
N ALL 
cases 
N 
controls 
OR 
(95% CI) 
N ALL 
cases 
N 
controls 
OR 
(95% CI) 
Heterogeneity 
I2, p 
Maternal and paternal age included as continuous variables 
Maternal age  
(5-year increment) 
9749 19803 
0.93 (0.90-0.96) 
7173 13054 
0.92 (0.89-0.96) 
10361 18667 
1.00 (0.95-1.06) 58%, 0.002 
 
Paternal age  
(5-year increment) 
1.07 (1.04-1.10) 1.08 (1.04-1.11) 1.05 (1.02-1.09) 9%, 0.36 
Maternal and paternal age included as categorical variables 
Maternal age (years)           
<25 2673 5158 Reference 2037 3430 Reference 2826 4949 Reference  
25-34 5905 12171 0.91 (0.85-0.98) 4327 8084 0.90 (0.83-0.98) 6287 11489 1.00 (0.88-1.15) 64%, <0.001 
≥35 1171 2474 0.83 (0.74-0.92) 809 1540 0.84 (0.74-0.95) 1248 2229 0.98 (0.84-1.15) 40%, 0.05 
Paternal age (years)           
<25 1396 2789 Reference 1115 1944 Reference 1443 2587 Reference  
25-34 5773 12009 1.03 (0.95-1.12) 4260 7936 1.05 (0.95-1.15) 6154 11407 1.06 (0.96-1.18) 13%, 0.31 
≥35 2580 5005 1.16 (1.05-1.28) 1798 3174 1.17 (1.04-1.32) 2764 4673 1.18 (1.03-1.36) 24%, 0.19 
 
Bold indicates statistical significance (p<0.05 for effect estimate and p<0.10 for heterogeneity). Maternal and paternal age are simultaneously introduced in all models. 
a Model 1: Odds Ratios are partially adjusted for index child’s age (categorical; <1, 1-4 [reference], 5-9, 10-14 years), sex, ethnicity (Caucasian vs. non-Caucasian), birth weight 
(continuous; 500 gr increment), maternal education (categorical; low, intermediate [reference], high) and study period (<1994, 1994-2003, 2004+). 
b Model 2: Odds Ratios are maximally adjusted for the same variables as in model 1 plus pre-term birth (yes vs. no), maternal smoking during pregnancy (yes vs. no), multiple 
pregnancy (yes vs. no) and birth order (continuous; 1, 2, ≥3). 
c Random-effects meta-analysis of maximally adjusted Odds Ratios from individual studies for any of the following variables that were available (<20% missing values in the 
total dataset): index child’s age (categorical; <1, 1-4 [reference], 5-9, 10-14 years), sex, ethnicity (Caucasian vs. non-Caucasian), birth weight (continuous; 500 gr increment), 
maternal education (categorical; low, intermediate [reference], high) pre-term birth (yes vs. no), maternal smoking during pregnancy (yes vs. no), multiple pregnancy (yes vs. no) 
and birth order (continuous; 1, 2, ≥3). 
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Table 3. Random-effects meta-analysis derived Odds Ratios (OR) and 95% Confidence Intervals (95% CI) 
from the 5 record-linkage studies (Canada, Quebec, QCLS; Denmark; Finland; US, California State, CCLRP; 
US, Washington State) on the association of the combined effect of maternal and paternal age at birth of the 
index child with childhood (0-14-year-old) acute lymphoblastic leukemia (ALL). 
ALL cases/ controls, 
OR (95% CI)a 
Paternal age  
<25 years 
Paternal age  
25-34 years 
Paternal age  
≥35 years 
Maternal age  
<25 years 
1181/4318 
0.84 (0.77-0.91) 
I2: 0%, p=0.53 
1036/3357 
0.96 (0.82-1.12) 
I2: 55%, p=0.07 
87/279 
1.17 (0.77-1.77) 
I2:45%, p=0.12 
Maternal age  
25-34 years 192/678 
0.88 (0.74-1.04) 
I2: 0%, p=0.71 
3382/10122 
Reference 
1114/3343 
1.05 (0.97-1.13) 
I2: 0%, p=0.80 
Maternal age  
≥35 years 
264/793 
1.07 (0.92-1.24) 
I2: 0%, p=0.64 
906/2582 
1.16 (1.04-1.28) 
I2: 11%, p=0.34 
Bold indicates statistical significance (p<0.05 for effect size and p<0.10 for heterogeneity). Maternal and 
paternal age are simultaneously introduced in all models. 
a Random-effect meta-analysis of maximally adjusted Odds Ratios from individual studies for any of the 
following variables that were available with <20% missing values in the total dataset: index child’s age 
(categorical; <1, 1-4 [reference], 5-9, 10-14 years), sex, ethnicity (Caucasian vs. non-Caucasian), birth weight 
(continuous; 500 gr increment), maternal education (categorical; low, intermediate [reference], high) pre-term 
birth (yes vs. no), maternal smoking during pregnancy (yes vs. no), multiple pregnancy (yes vs. no) and birth 
order (continuous; 1, 2, ≥3).   
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Table 4. Random-effects meta-analysisa derived Odds Ratios (OR) and 95% Confidence Intervals (95% CI) on the association of parental age at 
birth of the index child with childhood (0-14-year-old) acute lymphoblastic leukemia (ALL) in sub-analyses by index child’s age group, sex, 
ethnicity, and time period of diagnosis/recruitment, as determined by the 5 record-linkage studies (Canada, Quebec, QCLS; Denmark; Finland; US, 
California State, CCLRP; US, Washington State). 
Variable 
N 
ALL 
cases 
N 
Controls 
Maternal age  
(5-year increment) 
Paternal age  
(5-year increment) 
OR (95% CI)b Heterogeneity I2, p OR (95% CI)
b Heterogeneity I2, p 
Index child’s age group 
(years)    
 
 
 
<1 272 860 0.98 (0.81-1.18) 0%, 0.53 1.09 (0.92-1.29) 0%, 0.53 
1-5 5270 16302 1.04 (1.00-1.09) 0%, 0.89 1.05 (1.01-1.09) 0%, 0.83 
6-14 2621 8304 1.06 (0.97-1.16) 30%, 0.22 1.03 (0.90-1.19) 74%, 0.004 
Index child’s sex       
Males 4576 14293 1.04 (1.00-1.09) 0%, 0.54 1.07 (1.03-1.11) 0%, 0.64 
Females 3586 11180 1.05 (1.00-1.11) 0%, 0.83 1.00 (0.96-1.05) 0%, 0.96 
Index child’s ethnicity       
Caucasian 4771 13898 1.04 (0.99-1.08) 0%, 0.67 1.06 (1.01-1.08) 0%, 0.82 
Non-Caucasian 3348 11522 1.06 (1.01-1.11) 0%, 0.36 1.02 (0.97-1.06) 0%, 0.38 
Time period of 
diagnosis/recruitment    
 
 
 
1968-1993 2152 6076 1.01 (0.89-1.15) 56%, 0.06 1.01 (0.75-1.08) 0%, 0.95 
1994-2003 3446 10939 1.07 (1.00-1.15) 20%, 0.29 1.04 (0.99-1.09) 0%, 0.97 
2004-2015 2564 8458 1.03 (0.98-1.10) 0%, 0.50 1.06 (1.00-1.11) 0%, 0.40 
Bold indicates statistical significance (p<0.05 for effect size and p<0.10 for heterogeneity). Maternal and paternal age are simultaneously 
introduced in all models.  
a Random-effect meta-analysis of maximally adjusted Odds Ratios from individual studies for any of the following variables that were available, 
apart if stratified for the specific variable: index child’s age (categorical; <1, 1-4 [reference], 5-9, 10-14 years), sex, ethnicity (Caucasian vs. non-
Caucasian), birth weight (continuous; 500 gr increment), maternal education (categorical; low, intermediate [reference], high) pre-term birth (yes 
vs. no), maternal smoking during pregnancy (yes vs. no), multiple pregnancy (yes vs. no) and birth order (continuous; 1, 2, ≥3).    
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Figure 1. Distribution of (A) maternal and (B) paternal age at index child’s birth among controls across the 
participating studies. 
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Figure 2. Forest plots from the meta-analyses of classic non-record linkage and nested record-linkage case-
control studies on the association of (a) maternal and (b) paternal age (continuous in 5-year increments) with 
childhood (0-14-year-old) acute lymphoblastic leukemia (ALL). 
 
a. Maternal age (5-year increment) 
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b. Paternal age (5-year increment) 
 
 
Studies are presented in ascending order according to the mean maternal and paternal age. 
Maternal and paternal age are simultaneously introduced in all models. 
Random-effect meta-analysis of maximally adjusted Odds Ratios from individual studies for any of the 
following variables that were available (<20% missing values in the total dataset): index child’s age 
(categorical; <1, 1-4 [reference], 5-9, 10-14 years), sex, ethnicity (Caucasian vs. non-Caucasian), birth weight 
(continuous; 500 gr increment), maternal education (categorical; low, intermediate [reference], high) pre-term 
birth (yes vs. no), maternal smoking during pregnancy (yes vs. no), multiple pregnancy (yes vs. no) and birth 
order (continuous; 1, 2, ≥3).   
 
 
